New Filings & Updated Terms (2.8.19)

NEW FILINGS

NONE AT THIS TIME

TERMS ADDED

Company: TCR2 Therapeutics Inc.
Symbol: TCRR
Description: They are an innovative immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer.
Shares: 5 million
Price Range: $14.00-$16.00
Trade Date: 2/14
Underwriter(s): Jefferies, Leerink, BMO Capital
Co-Manager(s): Wedbush Capital, China Renaissance
Terms Added: 2-1-19

Company: Avedro, Inc
Symbol: AVDR
Description: They are a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses.
Shares: 5 million
Price Range: $14.00-$16.00
Trade Date: 2/14
Underwriter(s): BofA Merrill Lynch, JP Morgan, Cowen, Guggenheim Securities, SVB Leerink
Terms Added: 2-4-19

Company: Cibus Ltd.
Symbol: CBUS
Description: They are a biotechnology company using advanced technologies to develop desirable plant traits for the global seed industry.
Shares: 6.67 million
Price Range: $14.00-$16.00
Trade Date: 2/14
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Piper Jaffray
Terms Added: 2-4-19

Company: Stealth BioTherapeutics Inc.
Symbol: MITO
Description: They are a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction.
Shares: 6.2 million ADSs
Price Range: $12.00-$14.00
Trade Date: 2/15
Underwriter(s): Jefferies, Evercore, BMO Capital
Co-Manager(s): Nomura
Terms Added: 2-6-19